MedPath

Determination of Glycemic Response after Ingestion of Industrialized Enteral Diets Usually Used in Clinical Practice

Not Applicable
Conditions
Healthy subjects
M01.774.500
Registration Number
RBR-7rjx3k
Lead Sponsor
niversidade Federal de Minas Gerais - UFMG
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruitment completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

From 18 to 69 years of age; stable body weight; body mass index (BMI) between 18.5 and 24.9 kg / m2; normal glucose tolerance; without diabetes or pre-diabetes; no history of eating disorders; without gastrointestinal disturbances; no medications that affect glucose tolerance; without pregnancy; without breastfeeding; not intolerant or allergic to any of the foods

Exclusion Criteria

Volunteers using medications that could interfere with glycemia; which showed instability of body weight; any metabolic disease (diabetes mellitus; hypoglycemia; hypothyroidism)

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Determination of the glycemic index of ten industrialized enteral formulas commonly used in clinical practice, based on the method recommended by the Food and Agriculture Organization. For the determination of the GI of any food, the FAO recommends that it be offered to at least 6 healthy individuals, as well as the standard food, in this case a standardized GI glucose solution. To do this, each participant will perform the two formulas test and the glucose solution test, and the GI values of the formulas will be determined by the ratio of the area below the glycemic response curve of the enteral formula and the glucose solution, value multiplied by 100, so that the GI is expressed as a percentage. The evaluation period will comprise the interval of 3 to 5 days for each experiment (offer of two formulas and later offer of the standardized glucose solution).
Secondary Outcome Measures
NameTimeMethod
Secondary outcomes are not expected
© Copyright 2025. All Rights Reserved by MedPath